BR0013793A - Medicamentos profiláticos e terapêuticos para doenças oftálmicas - Google Patents

Medicamentos profiláticos e terapêuticos para doenças oftálmicas

Info

Publication number
BR0013793A
BR0013793A BR0013793-6A BR0013793A BR0013793A BR 0013793 A BR0013793 A BR 0013793A BR 0013793 A BR0013793 A BR 0013793A BR 0013793 A BR0013793 A BR 0013793A
Authority
BR
Brazil
Prior art keywords
prophylactic
therapeutic drugs
diseases
ophthalmic diseases
ophthalmic
Prior art date
Application number
BR0013793-6A
Other languages
English (en)
Inventor
Hiroaki Naka
Kazuhito Kawabata
Hideki Tokushige
Original Assignee
Ono Pharmaceutical Co
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co, Senju Pharma Co filed Critical Ono Pharmaceutical Co
Publication of BR0013793A publication Critical patent/BR0013793A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Abstract

Patente de Invenção: "MEDICAMENTOS PROFILáTICOS E TERAPêUTICOS PARA DOENçAS OFTáLMICAS". A presente invenção fornece um medicamento profilático e terapêutico para doenças oftálmicas, especialmente doenças inflamatórias oftálmicas e úlcera da córnea, compreendendo como um ingrediente ativo um composto representado pela fórmula (I): ou um sal farmacologicamente aceitável ou hidrato disso.
BR0013793-6A 1999-09-06 2000-09-05 Medicamentos profiláticos e terapêuticos para doenças oftálmicas BR0013793A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25153899 1999-09-06
PCT/JP2000/006014 WO2001017527A1 (fr) 1999-09-06 2000-09-05 Agents destines a la prevention et a au traitement des maladies des yeux

Publications (1)

Publication Number Publication Date
BR0013793A true BR0013793A (pt) 2002-05-14

Family

ID=17224318

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013793-6A BR0013793A (pt) 1999-09-06 2000-09-05 Medicamentos profiláticos e terapêuticos para doenças oftálmicas

Country Status (14)

Country Link
US (1) US6624193B1 (pt)
EP (1) EP1213018A4 (pt)
JP (1) JP4682495B2 (pt)
KR (1) KR20020042667A (pt)
CN (1) CN1387436A (pt)
AU (1) AU6870800A (pt)
BR (1) BR0013793A (pt)
CA (1) CA2383971A1 (pt)
HU (1) HUP0202745A2 (pt)
MX (1) MXPA02002452A (pt)
NO (1) NO20021094L (pt)
NZ (1) NZ517556A (pt)
WO (1) WO2001017527A1 (pt)
ZA (1) ZA200201819B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552082B2 (en) * 2000-06-29 2003-04-22 Ono Pharmaceutical Co., Ltd. Solution of N-[o-(p-pivaloyloxybenzenesulfonylamino)benzoyl] glycine monosodium salt tetra-hydrate and drug product thereof
EP1312356B1 (en) 2000-08-25 2012-10-17 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations
US7315848B2 (en) * 2001-12-12 2008-01-01 Aaron Pearse Web snippets capture, storage and retrieval system and method
DE602004013420T2 (de) 2003-01-21 2009-06-04 Senju Pharmaceutical Co., Ltd. Wässrige flüssige zubereitung mit 2-amino-3-(4-bromobenzoyl)phenylessigsäure
ES2534904T3 (es) * 2003-01-22 2015-04-30 Senju Pharmaceutical Co., Ltd. Preparación de absorción percutánea para el tratamiento de enfermedad oftálmica, uso del mismo y método para la migración del remedio oftálmico en el tejido tópico en los ojos
US8748402B2 (en) 2004-06-07 2014-06-10 Bausch & Lomb Pharma Holdings Corp. Ophthalmic formulations and uses thereof
US8372814B2 (en) * 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
EP1852106A4 (en) * 2005-02-17 2009-08-26 Senju Pharma Co SOLID OPHTHALMIC MEDICINE FOR EXTERNAL USE
CN104614873A (zh) 2006-09-29 2015-05-13 庄臣及庄臣视力保护公司 用于治疗眼变态反应性的方法和眼科装置
EP2155162B1 (en) * 2007-05-04 2012-11-21 Bausch & Lomb Incorporated Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
CA2686866A1 (en) * 2007-05-07 2008-11-13 Erning Xia Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
US8300252B2 (en) * 2008-06-18 2012-10-30 Livescribe, Inc. Managing objects with varying and repeated printed positioning information
TW201023912A (en) * 2008-12-05 2010-07-01 Alcon Res Ltd Pharmaceutical suspension
MX2011008680A (es) * 2009-03-03 2011-09-08 Alcon Res Ltd Composicion farmaceutica para el suministro de compuestos inhibidores de la tirosina cinasa receptora (rtki) para los ojos.
US8912236B2 (en) * 2009-03-03 2014-12-16 Alcon Research, Ltd. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
PL2968650T3 (pl) 2013-03-14 2019-05-31 Panoptica Inc Preparaty do oczu do dostarczania leku do tylnego fragmentu oka
US10383885B2 (en) 2015-06-16 2019-08-20 Rong-Tsun Wu Method for treating or preventing dry eyes
US11058713B2 (en) * 2017-06-29 2021-07-13 Advaite LLC. Treatment and diagnosis of ocular surface disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0320253A (ja) * 1988-06-13 1991-01-29 Ono Pharmaceut Co Ltd ピバル酸　ｐ―置換フェニルエステル誘導体、それらの製造方法およびそれらを有効成分として含有するエラスターゼ阻害剤
US5017610A (en) * 1988-06-13 1991-05-21 Ono Pharmaceutical Co., Ltd. Derivatives of p-substituted phenyl ester of pivalic acid
JPH03503055A (ja) * 1988-10-27 1991-07-11 ユニバーシティー オブ ケンタッキー リサーチ ファウンデーション 人の白血球エラスターゼ阻害剤およびその製造方法およびその使用
EP0519354B1 (en) 1991-06-18 1997-12-10 Fujisawa Pharmaceutical Co., Ltd. A prophylactic/therapeutic composition containing WS7622A for preventing or treating disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis
GB9115811D0 (en) 1991-07-22 1991-09-04 Fujisawa Pharmaceutical Co Fr901451 substance,process for preparation thereof and use thereof
JPH05194366A (ja) * 1991-10-25 1993-08-03 Ono Pharmaceut Co Ltd グリシン誘導体・モノナトリウム塩・４水和物、その製造方法、それを含有する薬剤および該誘導体の中間体の製造方法
EP0539223A1 (en) 1991-10-25 1993-04-28 Ono Pharmaceutical Co., Ltd. Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase

Also Published As

Publication number Publication date
NZ517556A (en) 2003-08-29
MXPA02002452A (es) 2004-09-10
EP1213018A1 (en) 2002-06-12
CN1387436A (zh) 2002-12-25
NO20021094L (no) 2002-05-06
KR20020042667A (ko) 2002-06-05
HUP0202745A2 (hu) 2003-01-28
WO2001017527A9 (en) 2001-06-21
WO2001017527A1 (fr) 2001-03-15
AU6870800A (en) 2001-04-10
NO20021094D0 (no) 2002-03-05
ZA200201819B (en) 2003-05-28
JP4682495B2 (ja) 2011-05-11
EP1213018A4 (en) 2004-04-14
CA2383971A1 (en) 2001-03-15
US6624193B1 (en) 2003-09-23

Similar Documents

Publication Publication Date Title
BR0013793A (pt) Medicamentos profiláticos e terapêuticos para doenças oftálmicas
GEP20074208B (en) Substituted amides active at the cannabinoid-1 receptor
NO20045656L (no) Oftalmologisk anvendelse av roflumilast for behandlingen av oyesykdommer
DE60128258D1 (de) Indanylderivate zur Behandlung von Atemwegserkrankungen
NO950297L (no) Prolinamidderivater
BRPI0509863A (pt) liberação de fármaco para fundo de olho
AR023972A1 (es) Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
DE69906518D1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
PT1256340E (pt) Sistema terapeutico transdermico aperfeicoado para o tratamento da doenca de parkinson
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
SE0102440D0 (sv) New compound
HK1045464A1 (en) Use of sulfodehydroabietic acid for the treatment of inflammatory bowel disease
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
GR3025568T3 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia.
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
SE9901572D0 (sv) New compounds
MXPA05014143A (es) Derivados de cumarina para el tratamiento de trastornos oftalmicos.
BR0011845A (pt) Complexo farmacêutico
BR0009327A (pt) Composição farmacêutica para a terapia de sintomas do trato urinário inferior
MXPA05008883A (es) Agente terapeutico para enfermedad hemorroidal.
HUP0301334A2 (hu) Szubsztituált akriloil-disztamicin-származékokat és taxánokat és/vagy antimetabolitokat tartalmazó kombinált tumorellenes kompozíciók
NO993911D0 (no) Remedier/Forebygningsmidler for åndedrettssykdommer
BR0316823A (pt) Uso de levocetirizina ou um sal desta farmaceuticamente aceitável
DE60026559D1 (de) Arzneimittel gegen essstörungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1927 DE 11/12/2007.